News

Filter

Actavis settles with Mallinckrodt over Exalgo 32mg; Teva gains FDA OK for Adderall XR

14-02-2013

US generics drug major Actavis (NYSE: ACT) has reached a settlement with Mallinckrodt (NYSE: MKG) on…

ActavisAdderall XRExalgoGenericsMallinckrodtNeurologicalNorth AmericaPatentsRegulationShireTeva Pharmaceutical Industries

Merck & Co prevails in Temodar law suit against Barr/Teva on appeal; Court upholds Shire’s Vyvanse exclusivity

11-11-2010

US drug giant Merck & Co (NYSE: MRK) says that a federal appellate court ruled in its favor in a patent…

Barr LaboratoriesLegalMerck & CoNeurologicalOncologyPatentsPharmaceuticalShireTemodarTeva Pharmaceutical IndustriesVyvanse

US FDA rejects Teva’s second try to block generic Copaxone; Shire sues Actavis over Intuniv

14-05-2010

The US Food and Drug Administration has rejected a second Citizen Petition from Israel-based Teva Pharmaceutical…

ActavisCopaxoneGenericsIntunivNeurologicalPatentsPharmaceuticalRegulationShireTeva Pharmaceutical Industries

Company news briefs

26-01-2004

- Leading generics maker Teva Pharmaceutical Industries of Israel has received permission from the US…

Aventis PharmaDrug DiscoveryShireTeva Pharmaceutical Industries

COMPANY SPOTLIGHT

Menarini

Back to top